Reports for LAMIVUDINE
Ingredient
LAMIVUDINE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LAMIVUDINE | 150MG | TABLET | Resolved | 2017-03-11 | 2017-05-16 | 664 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 300MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-05-23 | 14 |
| APO-LAMIVUDINE | 300MG | TABLET | Resolved | 2017-07-11 | 2017-08-31 | 15271 |
| HEPTOVIR | 5MG | SOLUTION | Resolved | 2017-08-10 | 2017-09-13 | 18727 |
| APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2018-01-03 | 2018-01-16 | 34878 |
| APO-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG | TABLET | Resolved | 2017-12-06 | 2018-07-03 | 31907 |
| PMS-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2018-02-06 | 2018-08-24 | 38860 |
| PMS-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2017-10-12 | 2018-10-03 | 25829 |
| APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-01-03 | 2019-01-23 | 71098 |
| MYLAN-ABACAVIR/LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2018-10-23 | 2019-02-16 | 65420 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| TRIZIVIR | 300MG 300MG 150MG | TABLET | Discontinued | 2019-09-18 | 2019-09-18 | 94278 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |
| HEPTOVIR | 5MG | SOLUTION | Discontinued | 2022-05-13 | 2022-07-22 | 160503 |
| HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
Showing 1 to 8 of 8